* Note Values calculated on a single administration
The analgesic properties of myrrh (Commiphora myrrha) have been known since antiquity and depend on the presence of bioactive sesquiterpenes. MyrLiq is an extract of C. myrrha with a standardized content of curzerene, furanoeudesma-1,3-diene and lindestrene (12.31 ± 0.05 g kg-1, 18.84 ± 0.02 g kg-1 and 6 , 23 ± 0.01 g kg-1, resp.) And a high total furanodiene content (40.86 ± 0.78 g kg-1). Subjects (aged 20 to 60 years) with different types of pain, including joint pain, muscle pain, lower back pain and menstrual cramps, were divided into two groups. The experimental group received 1 capsule / day containing 200 mg or 400 mg of MyrLiq (corresponding to 8 mg and 16 mg of bioactive furanodienes, respectively) For 20 days and the same number of capsules was administered to the placebo group without MyrLiq. A score was recorded for their previous experience with prescribed analgesics. The results demonstrated in all cases a strong reduction in pain and relief, demonstrating that MyrLiq has significant analgesic properties.
Here is the complete article, in case you want to learn more: